BD Biosciences microplate portfolio comprises three different surface families defined by a wide selection of biological (BD BioCoat), synthetic (BD PureCoat), or tissue culture-treated (BD Falcon ...

--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive ...

Oppenheimer analyst Matthew Biegler maintained a Buy rating on Tyra Bioscience (TYRA – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $28.61.

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has reported promising results from its diabetes animal study, revealing that its DehydraTECH-liraglutide and DehydraTECH-CBD ...

Bright Minds Biosciences Inc, headquartered in the USA, was founded on March 8, 2021. The company is at the forefront of developing innovative treatments for neuropsychiatric disorders ...

South Korean firm Ildong Bioscience says that raising consumer awareness and the entry of more players may be crucial for pushing the growth of postbiotics in the local market. The two postbiotic ...

A nim­ble Hous­ton start­up has raised a con­cise $28.4 mil­lion Se­ries A to start a mid-stage tri­al.

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Merck & Co. is putting down $30 million upfront to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset designed to take on the tough-to-treat brain cancer glioblastoma (GBM).

Please use one of the following formats to cite this article in your essay, paper or report: APA Axol Bioscience Ltd. (2024, October 22). Axol Bioscience acquires Phenocell to advance human ...